![Lindsay Abraham staff image](https://www.wcgclinical.com/wp-content/uploads/2020/07/Lindsay-Abraham-400x400-1-300x300.jpg)
Lindsay A. Abraham, JD, CIP
Regulatory Chair Director
Biography
Lindsay Abraham joined Western IRB (WIRB) in 2010 and is currently the Regulatory Chair Director at WCG IRB.
Ms. Abraham has co-authored several White Papers on topics related to IRB work, and both chairs Board meetings and provides guidance to the Board and clients regarding the interpretation of federal and state laws pertaining to IRB operations and functions. Ms. Abraham also presents education and training courses for Board members and staff.
Prior to joining WIRB, Ms. Abraham practiced in the field of family law, and holds a Juris Doctorate from Seattle University School of Law.
Latest insights by Lindsay
![](https://www.wcgclinical.com/wp-content/uploads/2020/07/itemeditorimage_5e3aed6627cf8.jpg)
Questions on the FDA’s 30-Day IND Review Period and IRB Approval
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2020/07/itemeditorimage_5e20be93c7561.jpg)
Series: Ask the IRB & IBC Experts
Is it possible to make a PI’s name or institution confidential on a consent form?
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2020/07/itemeditorimage_5d83aaa391d73.jpg)
Ethics in Clinical Research
If a Subject’s Care Is Divided Equally Between Two Caregivers, Who Should Sign Caregiver Consent?
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2020/07/itemeditorimage_5d2e121412451.jpg)
Clinical Trial Safety
Do we need to submit safety events from another site to our IRB?
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2020/07/itemeditorimage_5d03b43880645.jpg)
FDA & ICH
What are the IRB submission requirements for observational studies?
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2020/07/scientists-collaborating-whiteboard.jpg)
FDA & ICH